Episomal iPSC Reprogramming Vectors - Citations

Episomal iPSC Reprogramming Vectors - Citations

View additional product information for Episomal iPSC Reprogramming Vectors - Citations (A14703)

Showing 4 product Citations

Citations & References
Abstract
Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency.
AuthorsHu BY,Weick JP,Yu J,Ma LX,Zhang XQ,Thomson JA,Zhang SC
JournalProceedings of the National Academy of Sciences of the United States of America
PubMed ID20160098
For the promise of human induced pluripotent stem cells (iPSCs) to be realized, it is necessary to ask if and how efficiently they may be differentiated to functional cells of various lineages. Here, we have directly compared the neural-differentiation capacity of human iPSCs and embryonic stem cells (ESCs). We have ... More
Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells.
AuthorsHu K, Yu J, Suknuntha K, Tian S, Montgomery K, Choi KD, Stewart R, Thomson JA, Slukvin II,
JournalBlood
PubMed ID21296996
Reprogramming blood cells to induced pluripotent stem cells (iPSCs) provides a novel tool for modeling blood diseases in vitro. However, the well-known limitations of current reprogramming technologies include low efficiency, slow kinetics, and transgene integration and residual expression. In the present study, we have demonstrated that iPSCs free of transgene ... More
Efficient feeder-free episomal reprogramming with small molecules.
AuthorsYu J, Chau KF, Vodyanik MA, Jiang J, Jiang Y,
JournalPLoS One
PubMed ID21390254
Genetic reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) could offer replenishable cell sources for transplantation therapies. To fulfill their promises, human iPSCs will ideally be free of exogenous DNA (footprint-free), and be derived and cultured in chemically defined media free of feeder cells. Currently, methods are ... More
Human lymphoblastoid B-cell lines reprogrammed to EBV-free induced pluripotent stem cells.
AuthorsRajesh D, Dickerson SJ, Yu J, Brown ME, Thomson JA, Seay NJ,
JournalBlood
PubMed ID21708888
Generation of patient-specific induced pluripotent cells (iPSCs) holds great promise for regenerative medicine. Epstein-Barr virus immortalized lymphoblastoid B-cell lines (LCLs) can be generated from a minimal amount of blood and are banked worldwide as cellular reference material for immunologic or genetic analysis of pedigreed study populations. We report the generation ... More